{"id":8406,"date":"2021-12-16T13:28:02","date_gmt":"2021-12-16T18:28:02","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/lisiraglide-cas-320367-13-3-glukagon-benzeri-bir-peptit-1-glp-1-reseptor-agonistidir\/"},"modified":"2021-12-16T13:28:02","modified_gmt":"2021-12-16T18:28:02","slug":"lisiraglide-cas-320367-13-3-glukagon-benzeri-bir-peptit-1-glp-1-reseptor-agonistidir","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/tr\/product\/lisiraglide-cas-320367-13-3-glukagon-benzeri-bir-peptit-1-glp-1-reseptor-agonistidir\/","title":{"rendered":"Lisiraglide CAS 320367-13-3, glukagon benzeri bir peptit-1 (GLP-1) resept\u00f6r agonistidir"},"content":{"rendered":"

Lisiraglide CAS 320367-13-3, glukagon benzeri bir peptit-1 (GLP-1) resept\u00f6r agonistidir<\/strong><\/h2>\n

\u00dcr\u00fcn Ad\u0131: Lixisenatide
\nE\u015f anlaml\u0131lar: Lixisenatide, >98%;lixisenatide;Lixisenatide|Lixisenatide Acetate;Lixisenatide Acetate;Lixisenatide USP\/EP\/BP
\nCAS: 320367-13-3
\nMF: C265H347N61O
\nMW: 4858.53
\nEINECS:
\n\u00dcr\u00fcn Kategorileri:
\nMol Dosya: 320367-13-3.mol<\/p>\n

Lisiraglide glukagon benzeri bir peptit-1'dir (GLP-1) resept\u00f6r agonisti, kan \u015fekeri seviyelerini normalle\u015ftirmeye yard\u0131mc\u0131 olan bir hormon. \u0130lac\u0131n g\u00fcvenli\u011fi ve etkinli\u011fi, tip 2 diyabetli toplam 5.400 hastay\u0131 kaydeden 10 klinik \u00e7al\u0131\u015fmada de\u011ferlendirildi. Bu \u00e7al\u0131\u015fmalarda, lisiramid hem monoterapi olarak hem de metformin, s\u00fclfonil\u00fcreler, pioglitazon ve bazal ins\u00fclin dahil olmak \u00fczere FDA onayl\u0131 di\u011fer diyabet ila\u00e7lar\u0131 ile kombinasyon halinde de\u011ferlendirildi. Bu denemelerde, lisiramid kullan\u0131m\u0131 glislenmi\u015f hemoglobin (kan \u015fekeri d\u00fczeylerinin bir g\u00f6stergesi) d\u00fczeylerini iyile\u015ftirdi. Ek olarak, aterosklerotik kardiyovask\u00fcler hastal\u0131k riski ta\u015f\u0131yan tip 2 diyabetli 6.000'den fazla hasta, Kardiyovask\u00fcler Sonu\u00e7lar \u00c7al\u0131\u015fmas\u0131nda lisiramid veya plasebo ile tedavi edildi. Bu hastalarda lisiramid kullan\u0131m\u0131, olumsuz kardiyovask\u00fcler olay riskini art\u0131rmam\u0131\u015ft\u0131r. Lisiragide, tip 1 diyabetli hastalar\u0131 veya kanda keton veya idrar art\u0131\u015f\u0131 (diyabetik ketoasidoz) olan hastalar\u0131 tedavi etmek i\u00e7in kullan\u0131lmamal\u0131d\u0131r. Lisiramid ile ili\u015fkili en yayg\u0131n yan etkiler bulant\u0131, kusma, ba\u015f a\u011fr\u0131s\u0131, ishal ve ba\u015f d\u00f6nmesidir. Hipoglisemi, lisiramid ve s\u00fclfonil\u00fcreler ve\/veya bazal mahsul gibi di\u011fer antidiyabetik ila\u00e7larla tedavi edilen hastalarda g\u00f6r\u00fclen di\u011fer bir yayg\u0131n yan etkidir. Ek olarak, Lisiragib ile yap\u0131lan klinik \u00e7al\u0131\u015fmalarda \u015fiddetli a\u015f\u0131r\u0131 duyarl\u0131l\u0131k reaksiyonlar\u0131 (a\u015f\u0131r\u0131 duyarl\u0131l\u0131k dahil) bildirilmi\u015ftir.<\/p>\n

Lixisenatid, \u015fu anda diyabet tedavisinde kullan\u0131lan bir ila\u00e7t\u0131r ve ayn\u0131 zamanda bir GLP-1 resept\u00f6r agonistidir. Lixisenatide (Lyxumia), 2013 y\u0131l\u0131nda Avrupa'da pazarlamak i\u00e7in onaylanm\u0131\u015ft\u0131r ve kan \u015fekeri seviyeleri sadece ila\u00e7larla kontrol edilebilen hastalara, di\u011fer ila\u00e7lar veya ins\u00fclin ile birlikte g\u00fcnde bir kez uygulanan Lixisenatide bazl\u0131 enjekte edilebilir bir diyabet tedavisidir.< &>
\n Lisiraglide CAS 320367-13-3'\u00fcn Notu<\/strong>
\nYaln\u0131zca ara\u015ft\u0131rma ama\u00e7l\u0131 kullan\u0131m i\u00e7indir, insan kullan\u0131m\u0131 i\u00e7in de\u011fil<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00dcr\u00fcn Ad\u0131: Lixisenatid
\nAsetat;Lixisenatid USP\/EP\/BP
\nCAS: 320367-13-3
\nMF: C215H347N61O65S
\nMW: 4858.53
\nMol Dosya: 320367-13-3.mol<\/p>\n","protected":false},"featured_media":2114,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[353,353,353,353],"product_tag":[1278],"class_list":{"0":"post-8406","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-diyabet-peptidi","10":"product_tag-lisiraglide-cas-320367-13-3-is-a-glucagon-like-peptide-1-glp-1-receptor-agonist-tr","11":"desktop-align-left","12":"tablet-align-left","13":"mobile-align-left","15":"first","16":"instock","17":"shipping-taxable","18":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product\/8406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/comments?post=8406"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/media\/2114"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/media?parent=8406"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_brand?post=8406"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_cat?post=8406"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_tag?post=8406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}